Cargando…

Efficacy of Amitraz plus Metaflumizone for the treatment of canine demodicosis associated with Malassezia pachydermatis

This case reports the efficacy of metaflumizone plus amitraz spot-on formulation (ProMeris Duo(®); Fort Dodge) against generalized demodectic mange. A two year-old male dog presented at clinical examination with poor general condition, diffused alopecia, crusted lesions, pruritus, skin scales and pu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tarallo, Viviana D, Lia, Riccardo P, Sasanelli, Mariateresa, Cafarchia, Claudia, Otranto, Domenico
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654875/ https://www.ncbi.nlm.nih.gov/pubmed/19265536 http://dx.doi.org/10.1186/1756-3305-2-13

Ejemplares similares

Malassezia pachydermatis Carriage in Dog Owners
por: Morris, Daniel O., et al.
Publicado: (2005)

Malassezia pachydermatis keratomycosis in a dog
por: Ledbetter, Eric C., et al.
Publicado: (2016)

Susceptibility variation of Malassezia pachydermatis to antifungal agents according to isolate source
por: Weiler, Caroline Borges, et al.
Publicado: (2013)

Malassezia pachydermatis fungemia in an adult with multibacillary leprosy
por: Roman, Jorge, et al.
Publicado: (2016)

Malassezia spp. Yeasts of Emerging Concern in Fungemia
por: Rhimi, Wafa, et al.
Publicado: (2020)

Methodological Issues in Antifungal Susceptibility Testing of Malassezia pachydermatis
por: Peano, Andrea, et al.
Publicado: (2017)

Azole and terbinafine susceptibility testing of Malassezia pachydermatis in Japan
por: MURAYAMA, Nobuo, et al.
Publicado: (2023)

Antifungal susceptibility of Malassezia pachydermatis isolated from the external auditive conduct from dogs, in central Chile
por: Núñez, Andrea H., et al.
Publicado: (2022)

First Case of Catheter-related Malassezia pachydermatis Fungemia in an Adult
por: Lee, Jaehyeon, et al.
Publicado: (2019)

Antifungal Resistance Regarding Malassezia pachydermatis: Where Are We Now?
por: Peano, Andrea, et al.
Publicado: (2020)

New Therapeutic Candidates for the Treatment of Malassezia pachydermatis -Associated Infections
por: Sastoque, Angie, et al.
Publicado: (2020)

ERG11 Gene Variability and Azole Susceptibility in Malassezia pachydermatis
por: Díaz, Leyna, et al.
Publicado: (2022)

In Vitro Susceptibility of Malassezia pachydermatis Isolates from Canine Skin with Atopic Dermatitis to Ketoconazole and Itraconazole in East Asia
por: WATANABE, Shion, et al.
Publicado: (2013)

Malassezia pachydermatis fungemia in a preterm neonate resistant to fluconazole and flucytosine
por: Al-Sweih, Noura, et al.
Publicado: (2014)

CLSI broth microdilution method for testing susceptibility of Malassezia pachydermatis to thiabendazole
por: Nascente, Patrícia da Silva, et al.
Publicado: (2009)

Azole resistance of Malassezia pachydermatis causing treatment failure in a dog
por: Angileri, Martina, et al.
Publicado: (2018)

In vitro effects of omeprazole in combination with antifungal compounds against Malassezia pachydermatis
por: Shin, Juyoung, et al.
Publicado: (2023)

In Vitro Biofilm Formation by Malassezia pachydermatis Isolates and Its Susceptibility to Azole Antifungals
por: Čonková, Eva, et al.
Publicado: (2022)

Galleria mellonella as a Novelty in vivo Model of Host-Pathogen Interaction for Malassezia furfur CBS 1878 and Malassezia pachydermatis CBS 1879
por: Torres, Maritza, et al.
Publicado: (2020)

Genotyping and characterisation of the secretory lipolytic enzymes of Malassezia pachydermatis isolates collected from dogs
por: Teramoto, Hideshi, et al.
Publicado: (2015)

Draft Genome Sequence of the Animal and Human Pathogen Malassezia pachydermatis Strain CBS 1879
por: Triana, Sergio, et al.
Publicado: (2015)

A Ketoconazole Susceptibility Test for Malassezia pachydermatis Using Modified Leeming–Notman Agar
por: Hsieh, Bo-Young, et al.
Publicado: (2018)

Invasive Malassezia pachydermatis Infection in an 8-Year-Old Child on Lipid Parenteral Nutrition
por: Teoh, Zheyi, et al.
Publicado: (2022)

In Vitro Azole and Amphotericin B Susceptibilities of Malassezia furfur from Bloodstream Infections Using E-Test and CLSI Broth Microdilution Methods
por: Rhimi, Wafa, et al.
Publicado: (2020)

Production of Antihypertensive Angiotensin I-Converting Enzyme Inhibitor from Malassezia pachydermatis G-14
por: Jeong, Seung Chan, et al.
Publicado: (2005)

In Vitro Activity of Farnesol against Malassezia pachydermatis Isolates from Otitis Externa Cases in Dogs
por: Olabode, Ifarajimi Rapheal, et al.
Publicado: (2023)

Canine demodicosis: Hematological and biochemical alterations
por: Salem, N. Y., et al.
Publicado: (2020)

Heterologous expression and biochemical characterisation of the recombinant β-carbonic anhydrase (MpaCA) from the warm-blooded vertebrate pathogen malassezia pachydermatis
por: De Luca, Viviana, et al.
Publicado: (2021)

Susceptibility of Malassezia pachydermatis Clinical Isolates to Allopathic Antifungals and Brazilian Red, Green, and Brown Propolis Extracts
por: Deegan, Kathleen Ramos, et al.
Publicado: (2019)

A Cluster of Fluconazole-Resistant Malassezia pachydermatis in a Neonatal Intensive Care Unit — California, 2015–2016
por: Chinn, Raymond, et al.
Publicado: (2017)

Characterization of the species Malassezia pachydermatis and re-evaluation of its lipid dependence using a synthetic agar medium
por: Puig, Laura, et al.
Publicado: (2017)

A pilot study of the efficacy of wipes containing chlorhexidine 0.3%, climbazole 0.5% and Tris-EDTA to reduce Malassezia pachydermatis populations on canine skin
por: Cavana, Paola, et al.
Publicado: (2015)

Inhibitory Effects of Sulfonamide Derivatives on the β-Carbonic Anhydrase (MpaCA) from Malassezia pachydermatis, a Commensal, Pathogenic Fungus Present in Domestic Animals
por: De Luca, Viviana, et al.
Publicado: (2021)

Canine Angiostrongylosis in Naturally Infected Dogs: Clinical Approach and Monitoring of Infection after Treatment
por: Paradies, Paola, et al.
Publicado: (2013)

Efficacy of a topical application of Certifect(®) (fipronil 6.26% w/v, amitraz 7.48% w/v, (S)-methoprene 5.63% w/v) for the treatment of canine generalized demodicosis
por: Fourie, Josephus, et al.
Publicado: (2013)

Amitraz
por: Lee, Sangjin, et al.
Publicado: (2013)

Malassezia Infections in Humans and Animals: Pathophysiology, Detection, and Treatment
por: Velegraki, Aristea, et al.
Publicado: (2015)

Novel Antimicrobial Peptide from Temporin L in The Treatment of Staphylococcus pseudintermedius and Malassezia pachydermatis in Polymicrobial Inter-Kingdom Infection
por: Bellavita, Rosa, et al.
Publicado: (2020)

Whole-Genome Sequencing and De Novo Assembly of Malassezia pachydermatis Isolated from the Ear Canal of a Dog with Otitis
por: D’Andreano, S., et al.
Publicado: (2021)

Efficacy of oral afoxolaner for the treatment of canine generalised demodicosis
por: Beugnet, Frédéric, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6i3e1lv74r5san6cfq42l0tk4m